Navigating the Minefield of QTc Interval‐Prolonging Therapy in Nursing Facility Residents-Reference-Cited by-同舟云学术

Navigating the Minefield of QTc Interval‐Prolonging Therapy in Nursing Facility Residents

Published:2019-02-12 Issue:7 Volume:67 Page:1508-1515
ISSN:0002-8614
Container-title:Journal of the American Geriatrics Society
language:en
Short-container-title:J Am Geriatr Soc

Author:

Zarowitz Barbara J.¹^ORCID,Tisdale James E.²

Affiliation:

1. The Peter Lamy Center on Drug Therapy and AgingUniversity of Maryland, College of Pharmacy West Bloomfield Michigan

2. College of PharmacyPurdue University, School of Medicine, Indiana University Indianapolis Indiana

Publisher

Wiley

Subject

Geriatrics and Gerontology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgs.15810

Reference57 articles.

1. Drug-Induced Prolongation of the QT Interval

2. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER). Guidance for industry: E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non‐antiarrhythmic drugs. 2005.https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm073153.pdf. Accessed July 10 2018.

3. US Department of Health and Human Services Food and Drug Administration. Finding a better test for predicting the risk drugs pose to the heart. Regulatory Science in Action.https://www.fda.gov/drugs/scienceresearch/ucm560418.htm. Accessed May 11 2018.

4. Impact of FDA Drug Risk Communications on Health Care Utilization and Health Behaviors

5. Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence, Attributes, and Risk Factors of QT-Interval-Prolonging Drugs and Potential Drug-Drug Interactions in Cancer Patients: A Prospective Study in a Tertiary Care Hospital;Cureus;2024-05-17

2. Use of Electrocardiogram Monitoring in Adult Patients Taking High-Risk QT Interval Prolonging Medicines in Clinical Practice: Systematic Review and Meta-analysis;Drug Safety;2022-08-10

3. Quality, efficacy, safety—it is not enough!;European Journal of Clinical Pharmacology;2021-03-09

4. An Observational Study of QTc Prolongation in Critically Ill Patients: Identification of Incidence and Predictors;Indian Journal of Critical Care Medicine;2020